Sector consensus Gilead Sciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 05/12/2025 GMT			5-day change	1st Jan Change
121.22 ^USD	-1.14%		-3.67%	+31.23%

12-03	Soleno Therapeutics, Inc. Announces Demise of William G. Harris, Member of Board of Directors and Audit Committee Changes	CI
12-03	Gilead Sciences, Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-03-2025 10:50 AM

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
GILEAD SCIENCES, INC.	US$130.63	+7.77%	25
ELI LILLY AND COMPANY	US$1,056.7	+4.59%	27
JOHNSON & JOHNSON	US$203.42	+0.74%	24
ABBVIE INC.	US$243.55	+7.73%	29
ROCHE HOLDING AG	CHF 311.78	+0.28%	18
ASTRAZENECA PLC	GBX 197.15	+8.87%	19
NOVARTIS AG	CHF 131.65	-1%	19
MERCK & CO., INC.	US$106.62	+6.92%	26
NOVO NORDISK A/S	DKK 398.34	+28.66%	20
AMGEN INC.	US$324.25	-1.71%	27
PFIZER INC.	US$29.04	+11.56%	24
SANOFI	€106.13	+24.86%	22
VERTEX PHARMACEUTICALS INCORPORATED	US$487.28	+6.98%	25
BRISTOL-MYERS SQUIBB COMPANY	US$53.41	+2.41%	22
GSK PLC	GBX 18.33	+1.55%	18
CHUGAI PHARMACEUTICAL CO., LTD.	JP¥8,553.57	+3.89%	14
ALNYLAM PHARMACEUTICALS, INC.	US$492.17	+7.43%	24
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	CN¥81.04	+31.51%	18
TAKEDA PHARMACEUTICAL COMPANY LIMITED	JP¥4,946.14	+12.16%	14
Average	940.59	+8.70%	22
Weighted average by Cap.	610.62	+6.47%	23